SenesTech — Q3 2026 Earnings Summary

Financial Performance

• Preliminary third quarter 2026 revenue was approximately $1.1 million, the highest in company history.
• Revenue represents approximately 40% sequential growth compared to the second quarter of 2026.
• Revenue represents approximately 55% year-over-year growth compared to the third quarter of 2025.
• This marks the first quarter where revenue reached or exceeded the $1 million threshold.
• Preliminary results are unaudited and subject to adjustment pending quarter-end closing procedures.
• Definitive financial results, including specific earnings, profit margins, cash flow, and debt figures, are not disclosed in this release and are expected in the week of November 9, 2026.

Guidance and Future Outlook

• Management expects continued momentum in e-commerce, including higher subscription revenue expanding the recurring component of the revenue base.
• The company anticipates increasing traction in its B2B segment.
• Management expects continued, improved metrics going forward as earlier investments and transition costs are increasingly behind the company.
• The company plans to expand e-commerce and B2B significantly in a cost-effective manner.

Business Segments and Product Lines

• E-commerce is scaling as a controllable, data-driven acquisition engine.
• The vertical-focused B2B organization is gaining traction.
• Subscription revenue is increasing, improving the quality and visibility of revenue.
• Products include Evolve® and ContraPest® fertility control solutions, along with assessment and monitoring services.
• Solutions target reproduction to reduce rodent populations for consumer and professional markets, either independently or as part of integrated pest management (IPM) programs.

Market and Competitive Landscape

• SenesTech positions itself as the leader in rodent birth control and sustainable rodent population management.
• The company is working to establish an entirely new product category, which involves risks regarding time, expense, and uncertainty in building market awareness and customer acceptance.

Risks and Challenges

• Risks include the potential failure to realize benefits from e-commerce, B2B, and subscription strategies.
• There is a risk of unsuccessful commercialization of products or insufficient market acceptance.
• Challenges include the risk of failing to build and scale a professional B2B sales organization and execute a vertical-market strategy.
• Risks related to financial performance include the ability to fund operations and potential cash usage deviations from plans.
• Regulatory approval and regulation of products present ongoing risks.

Management Commentary and Tone

• CEO Michael Edell described the revenue milestone as "important" and a "second consecutive quarterly record."
• Management expressed confidence that the company is "on the right path" despite acknowledging there is still work to do.
• Edell noted that the quarter demonstrates progress on previously announced plans and strategies.
• The tone indicates a focus on laying the foundation for a larger company through cost-effective expansion.

Other Key Points

• Definitive third quarter financial results are scheduled for release the week of November 9, 2026.
• The company serves both consumer and professional markets.
• Contact information provided for investors (Robert Blum, Lytham Partners, LLC) and company (Tom Chesterman, CFO).